Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
9.08
-0.54 (-5.61%)
At close: Nov 20, 2026, 4:00 PM EST
9.07
-0.01 (-0.11%)
After-hours: Nov 20, 2026, 7:57 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $648.02 million as of November 20, 2026. It is the 12,022nd most valuable company in the world and the 2,455th biggest in the United States. Its market cap has increased by 153.83% in one year.
Market Cap
648.02M
Enterprise Value
374.21M
1-Year Change
153.83%
Global Rank
Country Rank
#2,455 United States
Category
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $648.02M, an increase of 82.65%. That is a compound annual growth rate of 19.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 648.02M | 236.59% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 (IPO) | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Attovia Therapeutics | 690.26M |
| Lexicon Pharmaceuticals | 681.21M |
| OmniAb | 679.71M |
| Apnimed | 669.84M |
| Nuvectis Pharma | 666.80M |
| Kura Oncology | 634.88M |
| Iambic Therapeutics | 621.42M |
| Janux Therapeutics | 616.73M |